Neurotrophic factors: from neurodevelopmental regulators to novel therapies for Parkinson's disease.
about
Microglia-Mediated Neuroinflammation and Neurotrophic Factor-Induced Protection in the MPTP Mouse Model of Parkinson's Disease-Lessons from Transgenic MiceDrug and gene delivery across the blood-brain barrier with focused ultrasoundCurrent Experimental Studies of Gene Therapy in Parkinson's DiseaseNeurorestoration induced by the HDAC inhibitor sodium valproate in the lactacystin model of Parkinson's is associated with histone acetylation and up-regulation of neurotrophic factors.TLR4 Signaling in MPP⁺-Induced Activation of BV-2 CellsIntranasal insulin protects against substantia nigra dopaminergic neuronal loss and alleviates motor deficits induced by 6-OHDA in ratsBack to the tubule: microtubule dynamics in Parkinson's disease.Intranasal gene delivery for treating Parkinson's disease: overcoming the blood-brain barrier.Heparin, Heparan Sulphate and the TGF-β Cytokine Superfamily.Novel Focused Ultrasound Gene Therapy Approach Noninvasively Restores Dopaminergic Neuron Function in a Rat Parkinson's Disease Model.A Small Molecule Activator of p300/CBP Histone Acetyltransferase Promotes Survival and Neurite Growth in a Cellular Model of Parkinson's Disease.Neurotrophic factor therapy for Parkinson's disease: past, present and future.Therapies for Parkinson's diseases: alternatives to current pharmacological interventions.Gdf-15 deficiency does not alter vulnerability of nigrostriatal dopaminergic system in MPTP-intoxicated mice.Review on PACAP-Induced Transcriptomic and Proteomic Changes in Neuronal Development and Repair.Downstream Consequences of Exercise Through the Action of BDNF.Alginate: Current Use and Future Perspectives in Pharmaceutical and Biomedical Applications
P2860
Q26773064-6308A754-250F-40DD-8527-391E7AC54095Q28080611-7A763C68-7389-40C5-B909-5F4D211D53B2Q33627771-69A2B803-EEB4-4A2A-9AC9-4B68EC02CD1DQ35978159-E0976967-276A-4BAC-980F-7F0DDFFA2FCFQ36530306-E5D7224C-AFD5-4621-B562-51E5FD8E4AE3Q36578704-F6316F42-C2DF-4CEA-BFC7-28EDB912FCEFQ37590635-1736C5B4-6BF4-4DC2-A343-E58DFBE0900BQ38569775-DA33036E-D93C-4C92-82C1-13FF1C7E976CQ38688063-309D8370-2502-4F0E-BBB0-5C8056A9C412Q38703346-1B237F26-A337-441E-8D6C-897B2887FA29Q38766912-AFCEAA5C-1105-4CC7-9227-FA5725A4FB6DQ38881852-B405E2BB-B161-49C4-8B30-48733A2E31A7Q38925121-5336D1B7-92A7-4C25-9861-BBD8C5ECE72CQ48793100-BBEA8E45-4C2C-4331-A975-E2E9F85A91AFQ55021241-6DE680C8-38BF-41AD-BB11-8E8B6F9144B7Q55300443-B37F4C5E-F609-472C-8C42-77AAB77CE8EDQ59124952-5D1F28C2-1779-454C-BC00-E006578A4ED9
P2860
Neurotrophic factors: from neurodevelopmental regulators to novel therapies for Parkinson's disease.
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年学术文章
@wuu
2014年学术文章
@zh-cn
2014年学术文章
@zh-hans
2014年学术文章
@zh-my
2014年学术文章
@zh-sg
2014年學術文章
@yue
2014年學術文章
@zh
2014年學術文章
@zh-hant
name
Neurotrophic factors: from neu ...... apies for Parkinson's disease.
@en
type
label
Neurotrophic factors: from neu ...... apies for Parkinson's disease.
@en
altLabel
Neurotrophic factors: from neu ...... rapies for Parkinson′s disease
@en
prefLabel
Neurotrophic factors: from neu ...... apies for Parkinson's disease.
@en
P2093
P2860
P50
P356
P1476
Neurotrophic factors: from neu ...... rapies for Parkinson's disease
@en
P2093
Aideen M Sullivan
Gerard W O'Keeffe
Shane V Hegarty
P2860
P304
P356
10.4103/1673-5374.143410
P407
P577
2014-10-01T00:00:00Z